SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-254941

SYN-031

[SYN] Zulu Ursa · 64y · Male · Chinese · BMI 26.2 · ECOG 1
SMCAS - Sunway Medical Centre AS · Medical Oncology · Dr. Lim Hui Yi
IIIB (T3, N2)Progression
ROS1
Clinical storyline

[SYN] Zulu Ursa, a 64-year-old Chinese male (never, ECOG 1), presented in 2023-12 with exertional dyspnea. Workup confirmed Neuroendocrine / Carcinoid (Stage III, ROS1). The MDT recommended platinum-based chemo-immunotherapy. Current status: Progression.

HPE Results
Adenocarcinoma: Solid with signet ring features, ROS1 rearranged
Clinical Stage
IIIB (T3, N2)
Pathological Stage
IIIB (T3, N2, M0)
Adenocarcinoma Subtype
Solid with signet ring features
CEA (ng/mL)
23.3
Tumor (CT/PET)
5.5 cm
PET SUV
7.03
NGS Results
ROS1 fusion positive (CD74-ROS1)